SciRhom
Martinsried
About SciRhom
SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academic and industry scientists with profound experience in antibody development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $84.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2024)
- Website: scirhom.com
- Phone: +49 (0)89 614 2412-31
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/scirhom-34271 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.